Sinaptica Therapeutics
Founded 2021 · 19 employees on LinkedIn · 7 known investors
Find your way into Sinaptica Therapeutics
Sign up to see every warm intro you have to Sinaptica Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sinaptica Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sinaptica is a medical device company developing noninvasive brain modulation therapies for Alzheimer's disease, led by scientific experts and experienced medtech executives.
Founders & leadership
Sinaptica Therapeutics was founded in 2021 by Scientific Co-Founder (University of Ferrara) and Scientific Co-Founder (Harvard Medical School).
SC

Scientific Co-Founder (University of Ferrara)Scientific Co-Founder
SC

Scientific Co-Founder (Harvard Medical School)Scientific Co-Founder
Investors · 7
Sony Ventures Corporationlisted by Sony Ventures CorporationTokyo
How we know: Sony Ventures Corporation's portfolio page · the VCSheet dataset · Not right? Tell us
In the news
Sinaptica Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference - BioSpacebiospace.com · Sep 2026Frequently asked questions
- What does Sinaptica Therapeutics do?
- Sinaptica is a medical device company developing noninvasive brain modulation therapies for Alzheimer's disease, led by scientific experts and experienced medtech executives.
- Who founded Sinaptica Therapeutics?
- Sinaptica Therapeutics was founded by Scientific Co-Founder (University of Ferrara), Scientific Co-Founder (Harvard Medical School) in 2021.
- Who are Sinaptica Therapeutics's investors?
- Sinaptica Therapeutics's investors include Bootstrap Venture Partners, Device of Tomorrow Capital, Healthtech Capital, NW Angel, Sony Ventures Corporation, Star51 Capital, Time Zero Capital.

